Cerebrospinal fluid lysozyme and beta 2-microglobulin in neurosarcoidosis.
The levels of lysozyme (LZM) and beta 2-microglobulin (beta 2m) were measured in the cerebrospinal fluid (CSF) and serum of 32 patients with sarcoidosis, 20 of whom had neurosarcoidosis. LZM was analyzed by a new radioimmunoassay (RIA) modification. CSF LZM was elevated in 15 of 20 patients with neurosarcoidosis but in only 4 of 12 patients with extraneural sarcoidosis. CSF beta 2m values were elevated in 13 of 19 and in one of 11 patients, respectively. In neurosarcoidosis, both CSF LZM and beta 2m correlated to CSF leucocytes but not significantly to CSF albumin thus suggesting that LZM and beta 2m were secreted from cells within the central nervous system (CNS). In patients with sarcoidosis, elevations of CSF LZM and beta 2m revealed disease activity in the CNS. Both analyses were also useful in the follow-up of neurosarcoidosis.
D000328:Adult; D000368:Aged; D006801:Humans; D008875:Middle Aged; D009113:Muramidase / Q000097:blood / Q000134:cerebrospinal fluid*; D009422:Nervous System Diseases / Q000134:cerebrospinal fluid*; D012507:Sarcoidosis / Q000097:blood / Q000134:cerebrospinal fluid*; D001613:beta 2-Microglobulin / Q000032:analysis / Q000134:cerebrospinal fluid*
D001613:beta 2-Microglobulin; D009113:Muramidase